Silvia Papa

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Multicenter invasive validation of the Venous Excess Ultrasound Score (VExUS) in patients referred for pulmonary hypertension.

Multicenter invasive validation of the Venous Excess Ultrasound Score (VExUS) in patients referred for pulmonary hypertension.

Journal: Chest

Published: May 11, 2026

Treatment of acute pulmonary embolism: anticoagulation, fibrinolysis, and thrombectomy compared.

Treatment of acute pulmonary embolism: anticoagulation, fibrinolysis, and thrombectomy compared.

Journal: European heart journal supplements : journal of the European Society of Cardiology

Published: May 08, 2026

Initial Combination of Macitentan With Riociguat in the Treatment of Pulmonary Arterial Hypertension.

Initial Combination of Macitentan With Riociguat in the Treatment of Pulmonary Arterial Hypertension.

Journal: Chest

Published: January 28, 2026

2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective.

2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective.

Journal: Vascular pharmacology

Published: December 20, 2025

The pleiotropic effects of sotatercept.

The pleiotropic effects of sotatercept.

Journal: Vascular pharmacology

Published: October 08, 2025

TAPSE/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension.

TAPSE/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension.

Journal: Circulation. Heart failure

Published: September 17, 2025

ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk score.

ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk score.

Journal: Vascular pharmacology

Published: August 27, 2025

Early SGLT2i Therapy Facilitates In-Hospital ARNI Introduction Improving 6-Month Systolic Function in Patients with HFrEF.

Early SGLT2i Therapy Facilitates In-Hospital ARNI Introduction Improving 6-Month Systolic Function in Patients with HFrEF.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions

Published: June 03, 2025

Oral Anticoagulants in Chronic Thromboembolic Pulmonary Hypertension: Tradition or Innovation?

Oral Anticoagulants in Chronic Thromboembolic Pulmonary Hypertension: Tradition or Innovation?

Journal: Journal of cardiovascular development and disease

Published: June 03, 2025

Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-up.

Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-up.

Journal: European heart journal

Published: May 12, 2025

Early in-hospital use of SGLT2i in heart failure patients with ischemic etiology.

Early in-hospital use of SGLT2i in heart failure patients with ischemic etiology.

Journal: Cardiovascular drugs and therapy

Published: May 02, 2025

Value of right heart haemodynamics for risk stratification of patients with pulmonary arterial hypertension at follow-up.

Value of right heart haemodynamics for risk stratification of patients with pulmonary arterial hypertension at follow-up.

Journal: ESC heart failure

Published: April 08, 2025

Showing 1-12 of 68

Last Updated: 09/26/2026